Head-to-head · WeighScore
Cora Health vs HealthRX
The verdict
HealthRX takes it — 77.5/100 to 72.5/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Cora Health | HealthRX |
|---|---|---|
| WeighScore | 72.5/100 | 77.5/100 |
| Grade | C | C+ |
| Site position | #87 | #36 |
| Semaglutide | $175/mo | $149 first month, then $165/month; $1,163 per 12-month subscription |
| Tirzepatide | $225/mo | $193 first month, then $214/month; $2,123 per 12-month subscription |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #87 · C
Strengths
- Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
- Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
- LegitScript Certified (seal ID 49690100 in footer)
- Flat per-tier pricing — no dose-escalation surcharge
- Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide
Where it loses points
- Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
- Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
- Lowest advertised prices require 12-month commitment with no partial refunds
- No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
- Founder names and funding undisclosed on site
Site position #36 · C+
Strengths
- Product pages publish due-today and next-charge tables
- Medication if approved, provider review and overnight shipping are included
- Longer plans offer a one-time purchase option without automatic renewal
Where it loses points
- Annual headline rates require payment for 12 months upfront
- Monthly subscription prices rise after the first payment
- Product navigation still shows older starting prices
- Injection supplies are not confirmed as standard inclusions
Featured provider
HealthRX
HealthRX scores 77.5/100 (C+). HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.